#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Postprandial hypoglycaemia Ventricular fibrillation Severe myoclonic epilepsy of infancy Immunodeficiency common variable Intracranial germ cell tumour Chronic hepatitis B Indolent systemic mastocytosis Duchenne muscular dystrophy gene carrier Herpes simplex Stiff person syndrome Thrombocytopenia Anal cancer recurrent Leukocyte adhesion deficiency Neovascular age-related macular degeneration Glomerulonephritis acute More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Basic Information Chondrosarcoma – Basic Information Osteosarcoma metastatic – Trials in Disease Soft tissue sarcoma – Treatment Prolymphocytic leukaemia – Trials in Disease Sjogren’s syndrome – Life with Disease Chondrosarcoma – Trials in Disease Loeys-Dietz syndrome – Treatment Marfan’s syndrome – Diagnostics Cholangitis sclerosing – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rigosertib Sodium 1,3-BUTYLENE GLYCOL Lenacapavir Sodium Edotreotide VELPATASVIR Bepranemab ANX007 Redasemtide Sodium Iodide (123 I) Tecaginlimab Bay 2927088 Cannabis Sativa Flower Ngm707 Elafibranor Epinephrine 12 Grass Pollen Mixture Linezolid Ataluren Cetrimide Wt1 Lamp Mrna Dc More therapies…

    Learn about Your Condition

    Pelvic venous thrombosis Progressive multiple sclerosis Neuropathy peripheral Primary hypogonadism Transitional cell carcinoma Chronic fatigue syndrome Becker's muscular dystrophy Skin angiosarcoma Peripheral artery stenosis Dermatomyositis Huntington's disease Eye inflammation External cephalic version Gestational diabetes Endometrial adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Atorvastatin for Preventing Episodic Migraine in Adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atorvastatin
    • Placebo
    Norway

  • Study on the Effectiveness of Eltrombopag in Combination with Other Drugs for Patients with Immune Thrombocytopenia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Avatrombopag
    • Eltrombopag
    • Ciclosporin
    Czechia

  • Study of Tucatinib, Etoposide, and Trastuzumab for Patients with Metastatic HER2+ Breast Cancer After Progression or Capecitabine Toxicity

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Tucatinib
    • Etoposide
    • Trastuzumab
    France

  • Study on Preoperative Treatment for HER2-Negative Breast Cancer Using Pembrolizumab, Paclitaxel, and Carboplatin in Patients Not Responding to Initial Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Poland

  • Study on the Impact of Dapagliflozin on Quality of Life and Exercise Capacity in Patients with Transthyretin Cardiac Amyloidosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acquired ATTR amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study of Daridorexant for Treating Insomnia in Patients with Mild Cognitive Impairment and Mild to Moderate Alzheimer’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    France
Previous Page
1 … 591 592 593 594 595 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!